We investigated whether CIDR-based ovulation-synchronization protocols inhibit secretion of prostaglandin (PG) F2α from the uterus in the following luteal phase in non-cycling beef cows. Ten early (a month) postpartum non-cycling Japanese Black beef cows were treated with (1) Ovsynch (GnRH analogue on Day 0, PGF2α analogue on Day 7, and GnRH analogue on Day 9; n=3), (2) Ovsynch+CIDR (Ovsynch protocol plus a CIDR for 7 days from Day 0; n=4), or (3) estradiol benzoate (EB) Ovsynch+CIDR (EB on Day 0 in lieu of the first GnRH treatment followed by the Ovsynch+CIDR protocol; n=3). An oxytocin challenge was administered on Day 24 to examine uterine PGF2α secretion. Plasma concentrations of 13,14-dihydro-15-keto-PGF2α were lower at 30-120 min after oxytocin administration in the Ovsynch+CIDR group and 75 min after administration in the EB Ovsynch+CIDR group than in the Ovsynch group (P<0.05). Plasma progesterone concentrations were higher from Days 1 to 7 in the Ovsynch+CIDR group and from Days 1 to 5 in the EB Ovsynch+CIDR group than in the Ovsynch group (P<0.05). The progesterone concentrations were higher on Days 27 and 29 in both CIDR-treated groups than in the Ovsynch group (P<0.05). In conclusion, in noncycling beef cows, CIDR-based ovulation-synchronization protocols inhibit uterine PGF22α secretion in the following luteal phase and prevent premature luteolysis as is seen with the Ovsynch protocol. Uterine PGF2α secretion (J. Reprod. Dev. 52: [497][498][499][500][501][502] 2006) vulation synchronization, such as Ovsynch or its modified protocols, has been used for timed artificial insemination (timed-AI) in postpartum beef cows [1] [2] [3] [4] [5] . In previous studies, we reported that a protocol using an intravaginal controlled internal drug release (CIDR) device in addition to Ovsynch (Ovsynch+CIDR) and another protocol using estradiol benzoate (EB) in lieu of the first g o n a d o t r o p i n -r e l e a s i n g h o r m o n e ( G n R H ) t r e a t m e n t o f t h e O v s y nc h +C I DR p ro t o co l improved the rate of conception following timed-AI in suckled early postpartum beef cows [4, 5] . An improved conception rate by the CIDR-based
protocols may be obtained when the proportion of non-cycling cows in the herd is high [3, 6] . Higher blood progesterone concentrations were observed at time of PGF 2α treatment in the Ovsynch+CIDR protocol in postpartum non-cycling beef cows than with the Ovsynch protocol in our previous study [5] . Higher blood progesterone concentrations in the luteal phase prior to estrus reduced uterine secretion of PGF 2α during the late luteal phase after estrus in dairy cows [7] and may then increase conception rates with AI [8, 9] . However, no differences have been reported in PGF 2α secretion b e t w e e n t h e C I D R -b a s e d o v u l a t i o nsynchronization and Ovsynch protocols in the following luteal phase in early postpartum noncycling beef cows.
The present study was performed to determine w h e t h e r t h e C I D R -b a s e d o v u l a t i o nsynchronization protocols affect secretion of PGF 2α from the uterus in the luteal phase after ovulation, as compared with Ovsynch, in early postpartum non-cycling beef cows.
Materials and Methods

Animals
This study was conducted from February to July 2003 on an experimental beef cattle station in the Northern Center of Agriculture Technology of Hyogo Prefecture, Tajima District, Japan. The cows were kept in feedlot-type pens for the duration of the experiment and were fed hay and concentrate to meet or exceed the Japanese Feeding Standard recommendations for beef cows that are nursing calves [10] . The cows were freely accessible by their healthy calves throughout the experiment, except during serial blood sampling for 4 h for oxytocin challenge. During the oxytocin challenge, the calves were close to their dam, but were separately by a fence and not able to suckle.
Treatment and sample collection
Clinically normal suckled postpartum Japanese Black beef cows without any problems around the previous parturition were used for this experiment. Ten cows around 3-wk postpartum with completed uterine involution but lack of a corpus luteum, which was determined by palpation per rectum, were treated with 500 µg cloprostenol (Day -10) intramascularly (im), and a subsequent treatment was given 9 days later (Day -1). These treatments were performed to maintain blood progesterone concentrations at a low level until start of ovulation synchronization in case any of the cows had a corpus luteum. However, the plasma progesterone concentrations on Days -10 and -1 (just before PGF2α treatment), which were determined later, were below 0.5 ng/ml on both days in all cows. Thus, these cows were diagnosed as non-cycling. On the day following the second cloprostenol t r e a t m e n t ( D a y 0 : s t a r t o f o v u l a t i o nsynchronization protocol), the cows (age 5.2 ± 0.3 years, parity 3.7 ± 0.3, days postpartum 33.4 ± 0.6 days, body weight 375.9 ± 8.0 kg, height 128.9 ± 0.9 cm; mean ± S.E.M.) were randomly separated into three groups. The cows in the control group Blood samples were collected on Days -10 and -1, once daily from Days 0 to 9, and on Days 13, 16, 20, 23, 24, 27, and 29. Blood was collected from the jugular vein into heparinized vacutainers and was centrifuged at 800 × g for 20 min. Plasma was separated and stored at -30 C prior to hormone assays.
On Day 24, the cows were challenged with a single intravenous (iv) oxytocin infusion (0.21 IU/ kg) to examine PGF2α secretion from the uterus. Blood samples were collected at 15-min intervals from 60 min before the oxytocin treatment until 180 min after to determine the concentration of 13,14dihydro-15-keto-PGF 2α (PGFM; the major PGF 2α metabolite). Blood was collected into heparinized syringes through a 16-g indwelling catheter (Nippon Sherwood, Tokyo, Japan) that was inserted into the jugular vein of the cows. The plasma was separated and stored as described above.
Hormone assays
The concentration of progesterone in blood plasma was measured by radioimmunoassay, as described previously [4, 5] , using the processed standard curve. Anti-progesterone-11-bovine serum albumin serum (GDN no. 337) was used in this assay, and the sensitivity was 78 pg/ml. The intra-assay CV for progesterone was 14.4% (n=6). All samples for each experiment were assayed. The progesterone concentration was measured in all blood samples.
The concentration of estradiol-17β in the plasma was measured by radioimmunoassay, as described previously [4, 5] . Before assaying the samples, the accuracy of the assay was estimated using the processed standard curve. Anti-estradiol-17β-6bovine serum albumin serum (GDN no. 244) was used in this assay, and the sensitivity was 0.20 pg/ ml. The intra-assay CV for estradiol-17β was 14.3% (n=6). All samples were assayed. Estradiol-17β was measured in blood samples collected on Days 7, 8, 9, 13, 16, 20 , 23 and 24.
The concentration of PGFM in the plasma was measured by radioimmunoassay, as described previously [11] , using the processed standard curve. Anti-PGFM-bovine serum albumin serum (WS no. 4468-8) was used in this assay, and the sensitivity was 6.25 pg/ml. The intra-assay CV for PGFM was 20.0% (n=6). The PGFM concentration was measured in samples from the oxytocin challenge test.
Statistical analysis
Differences in means between treatment groups for age, parity, weight-height ratio and postpartum interval were analyzed by ANOVA (SAS Version 8.2 software; SAS Institute Japan Inc., Tokyo, Japan).
For concentrations of progesterone, estradiol-17β and PGFM, the effects of treatment, day (time), and treatment by day (time) interaction were evaluated by repeated measures ANOVA using the mixedmodel procedure (SAS Version 8.2 software). Differences in mean concentrations between any two treatment groups on specific days and between days in each treatment group were analyzed by least significant difference. Differences were taken as significant at P<0.05.
Results
No significant differences were found among the Ovsynch, Ovsynch+CIDR, and EB Ovsynch+CIDR groups for age of the cows, parity, weight-height ratio (overall, 2.9 ± 0.1), or postpartum interval.
There were effects of time and treatment by time (P<0.001) on plasma PGFM concentrations, but no effect of treatment (P>0.15). In all groups, the PGFM concentrations increased rapidly from the For plasma progesterone concentrations, there were effects of treatment (P<0.01), day (P<0.001), and treatment by day (P<0.001). Progesterone concentrations were greater from Days 1 to 7 in the Ovsynch+CIDR group (P<0.05) and from Days 1 to 5 in the EB Ovsynch+CIDR group (P<0.05) than in the Ovsynch group (Fig. 2) . The progesterone concentrations were higher on Days 27 and 29 in both the CIDR-treated groups than in the Ovsynch group (P<0.05).
For plasma estradiol-17β concentrations, there was an effect of day (P<0.001), but no effect of treatment or of treatment by day (P>0.15). Thus, changes in estradiol-17β concentration in all groups were combined and analyzed as an 'allcombined group' (Fig. 3) . The estradiol-17β concentrations increased from Days 7 to 8 (P<0.01) and decreased from Days 9 to 13 (P<0.001) in the all-combined group.
Discussion
Plasma PGFM concentrations following the oxytocin challenge were reduced in both the CIDRtreated groups relative to the Ovsynch group in the luteal phase after synchronized ovulation in the postpartum non-cycling bee f cows. Also, progesterone concentrations were elevated from Day 1 to Day 7 in the Ovsynch+CIDR group and from Day 1 to Day 5 in the EB Ovsynch+CIDR group, as compared with the Ovsynch group. However, the progesterone and estradiol-17β concentrations from Day 8 to Day 24 (day of oxytocin challenge) in the both the CIDR-treated groups did not differ from the Ovsynch group. These results demonstrate the delayed inhibitory e f f e c t s o f i n c r e a s e d b l o o d p r o g e s t e r o n e concentrations due to CIDR-based protocols with Ovsynch on uterine PGF2α secretion in the subsequent luteal phase in early postpartum noncycling beef cows. Similar delayed effects of different levels of progesterone in blood during one estrus cycle on PGF 2α secretion in the next cycle have been reported in cycling dairy cows [7] .
In the present study, reductions in plasma PGFM concentrations were observed following the oxytocin challenge after their peak (from 30 to 120 min after oxytocin in the Ovsynch+CIDR group and at 75 min in the EB Ovsynch+CIDR group) in the CIDR-treated groups compared with the Ovsynch group, but not at the peak values. These results may indicate that signal transduction by oxytocin stimulus ceased earlier, possibly due to enhanced desensitization or receptor downregulation in the CIDR-treated groups relative to the Ovsynch group. Alternatively, the dose of oxytocin used for this experiment may be higher than the optimal amount for examination of the responsiveness of PGF2α secretion to oxytocin in beef cows, since we used the dosage recommended for lactating dairy cows [7] .
In the present study, plasma progesterone concentrations were below 0.5 ng/ml for 7 days after the first GnRH treatment in the Ovsynch cows. Almost no increases of progesterone were observed after the start of the Ovsynch protocol in our previous study of postpartum non-cycling beef cows [5] . In another study [12] , approximately half of the early postpartum suckled beef cows given G n R H h a d e i t h e r n o i n c r e a s e i n p l a s m a progesterone concentration or a short increase (that lasted <7 days) while the remaining half of the cows showed an increase in their progesterone concentrations that lasted over 7 days. Progesterone concentrations fell below 0.5 ng/ml before Day 27 (17 days after the expected day of ovulation) in the Ovsynch group. Earlier regression of the corpus luteum in the Ovsynch group was expected since the life span of a corpus luteum formed after the first ovulation is usually short in postpartum cows [14] . On the other hand, the progesterone concentrations remained high on Day 27 in both the CIDR-treated groups. This data suggests that CIDR-based protocols prevent premature luteal regression from occurring as is seen with the Ovsynch protocol in non-cycling beef cows, perhaps by suppressing uterine PGF2α secretion. Improved conception rate have been reported by adding CIDR to Ovsynch (Co-synch) in postpartum beef [3] [4] [5] and dairy [6] cows when the herds included many non-cycling animals. We infer that the improved conception with CIDRbased protocols in early postpartum cows may be due to suppression of uterine PGF 2α secretion at the critical period for conception in non-cycling cows by increasing blood progesterone concentrations prior to timed-AI. In this regard, higher conception rates were observed for dairy cows with higher progesterone concentrations before AI [8, 9] .
We did not investigate the mechanism by which increased progesterone concentrations before synchronized ovulation suppress uterine PGF 2α secretion in the luteal phase following ovulation. In early postpartum beef cows that are expected to show premature luteal regression, concentrations of oxytocin receptors in the endometrium on day 5 (day 0=day of estrus) were greater than in cows pretreated with progestogen, which showed normal luteal lifespan, but the concentrations of progesterone receptors were lower [13] . We infer that pretreatment with progesterone enhances the subsequent ability of progesterone to reduce endometrial oxytocin receptor concentrations and therefore decrease uterine responsiveness to oxytocin [14] . On the other hand, estradiol may enhance uterine responsiveness to oxytocin by increasing the synthesis of endometrial oxytocin receptors [11, 15] . In the present study, there was less inhibition of uterine PGF 2α secretion in the EB Ovsynch+CIDR group than in the Ovsynch+CIDR group. Blood estradiol-17β concentrations increase over the estrous level for several days after administration of a 2 mg estradiol benzoate treatment in beef cows [16] . Thus, higher estradiol concentrations before synchronized ovulation may interfere with the inhibitory effects of increased progesterone on uterine PGF2α secretion in the subsequent luteal phase. The lifespan of the corpus luteum in the EB Ovsynch+CIDR group was similar to that in the Ovsynch+CIDR group, although inhibition of uterine PGF 2α secretion was less in the EB Ovsynch+CIDR group than in the Ovsynch+CIDR group. The lesser inhibition of PGF 2α secretion observed in the EB Ovsynch+CIDR group may be enough to prevent premature luteal regression in the Ovsynch group, although this needs to be confirmed in further studies.
In conclusion, in non-cycling beef cows, CIDRbased protocols raised blood progesterone concentrations relative to the Ovsynch protocol before synchronized ovulation, and this probably inhibited uterine PGF 2α secretion in the subsequent luteal phase. Also, the CIDR-based protocols prevented premature luteal regression as is seen in the Ovsynch protocol, perhaps by inhibiting uterine PGF 2α secretion.
